Tuesday, June 2, 2020
The Hemp CBD Times. Every minute hemp cbd industry news.

Category: Epidiolex


Week in Review: Cannabis firm iAnthus can’t make interest payments, MA gov sued, COVID-19 causes slide in adult-use marijuana sales & more

Multistate marijuana operator iAnthus defaulted on interest payments, in part blaming the coronavirus. In addition, the New York-based company revealed…

By hempcbdtimes , in Canadian Medical Marijuana & Cannabis Industry News Colorado Medical Cannabis Business & Marijuana Legal News Coronavirus Epidiolex Featured Marijuana Business & Cannabis Industry News Illinois Medical Cannabis Business & Marijuana Legal News International Marijuana Business News Marijuana Dispensary & Cannabis Store News Marijuana Stocks & Publicly Traded Cannabis Companies Massachusetts Medical Cannabis Business & Marijuana Legal News Medical Cannabis Industry & Recreational Marijuana Business News Nevada Medical Cannabis Business & Marijuana Legal News New York Medical Cannabis Business & Marijuana Legal News United States Cannabis Industry & Marijuana Business News week in review , at April 11, 2020

DEA removes cannabis drug Epidiolex from controlled substances list

Epidiolex, the only plant-derived cannabis drug approved by the U.S. Food and Drug Administration, is no longer considered a controlled…

By hempcbdtimes , in Cannabis Industry & Marijuana Business Briefs DEA Epidiolex FDA Featured Marijuana Business & Cannabis Industry News GW Pharmaceuticals International Marijuana Business News Marijuana Legalization and Regulatory News for Cannabis Businesses Medical Cannabis Industry & Recreational Marijuana Business News United States Cannabis Industry & Marijuana Business News , at April 7, 2020